This vaccine is a milestone against malaria- SII
At the same time, Serum Institute of India (SII) CEO Adar Poonawala said that for a long time, malaria disease has been endangering the lives of crores of people around the world. He said that this is why the approval of the vaccine is a milestone in fighting malaria. SII said that after receiving WHO approval, additional regulatory approval is expected soon and the use of R21/Matrix-M vaccine will start early next year. Let us tell you, this vaccine is currently being used in Ghana, Nigeria and Burkina Faso.